Transvaginal Mesh Lawsuit

J&J trying to recover from setbacks

Although Johnson & Johnson’s overall profit fell 10.6 percent to $3.5 billion in the first quarter of 2013, over-the-counter sales through the company’s consumer division are up 14 percent in the United States, according to a story in the Philadelphia Inquirer.

The company is putting more Tylenol and Motrin on stores shelves through its McNeil Consumer Healthcare Unit, located outside Philadelphia. Although McNeil also has plants in Lancaster, Pa., and in Puerto ...

continue reading...

Woman writes of ordeal with mesh implant

Scots newspaper Daily Record recently printed a letter that a woman wrote to Scotland’s health secretary, detailing the health problems she’s endured as a result of getting a vaginal mesh implant. She describes herself as “one of the many, many Scots women whose lives have been devastated by mesh surgery.”

But the devices, implanted to treat urinary incontinence and pelvic organ prolapse, have generated complaints globally about their tendency to erode in ...

continue reading...

Investing blog warns about J&J

An investing blog on CNBC.com warns potential investors about health care giant Johnson & Johnson.

The stock is already up more than 22 percent on the year, the blog entry says, and trading at a price/earnings ratio more than twice that of rival Abbott Laboratories. But the entry points out that investors are worried about the company’s prospects for organic growth, especially in light of its reputation still being in “recovery” after ...

continue reading...

J&J baby powder contaminated with carcinogen

According to a story in the International Business Times, a batch of baby powder from a Johnson & Johnson plant in India was found to be contaminated with a carcinogen. That finding prompted the Food and Drug Administration to cancel Johnson & Johnson’s license to manufacture the powder at that plant.

In recent years, Johnson & Johnson has been obliged to recall nearly 300 million packages of over-the-counter medications, including Motrin, children’s ...

continue reading...

Johnson & Johnson shareholders unhappy with management

A story in the Washington Post says that several Johnson & Johnson shareholders spoke of their dissatisfaction with the company during their annual meeting recently. Their complaints focused on a long string of product recalls, ethical lapses and excessive executive pay.

In 2010, the company’s McNeil Consumer Healthcare unit recalled more than 280 million packages of over-the-counter medications, which included Motrin, children’s Tylenol liquid and Benadryl.

Also in 2010, Johnson & Johnson’s DePuy ...

continue reading...

Woman thought mesh would be easiest treatment

A report on News Channel 4 out of Oklahoma tells the story of a woman who received a vaginal mesh implant in the belief that it was the most advanced, minimally invasive technique available to cure her urinary incontinence.

Instead, she ended up in extreme pain, and trying unsuccessfully for three years to get the surgery necessary to remove the device. The story says she has joined hundred ...

continue reading...
Page 5 of 29 «...34567...»